These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4956463)

  • 21. Dissociation of Clostridium botulinum type-E-toxin.
    Kitamura M; Sakaguchi S; Sakaguchi G
    Biochem Biophys Res Commun; 1967 Dec; 29(6):892-7. PubMed ID: 4965663
    [No Abstract]   [Full Text] [Related]  

  • 22. [Surface antigen of Clostridium botulinum. 3. Isolation and characterization of glycopeptide antigen of E type organism].
    Takumi K; Nagao S; Kawata T
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):83. PubMed ID: 765571
    [No Abstract]   [Full Text] [Related]  

  • 23. [Problem of non-soluble antigens in the identification of Cl. botulinum. I. Precipitation and immunofluorescence studies].
    Cygan Z
    Pol Arch Weter; 1972; 15(2):245-64. PubMed ID: 4572437
    [No Abstract]   [Full Text] [Related]  

  • 24. Physiology of toxin production by Clostridium botulinum types A and B. IV. Activation of the toxin.
    BONVENTRE PF; KEMPE LL
    J Bacteriol; 1960 Jan; 79(1):24-32. PubMed ID: 13802636
    [No Abstract]   [Full Text] [Related]  

  • 25. Botulinal toxin and toxoid as antigens.
    Heimach RC; Champion LA; Sugiyama H
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):151-4. PubMed ID: 4920940
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antigenic structure of Cl. botulinum types E and F].
    Bulatova TI; Perova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):28-32. PubMed ID: 4920529
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative immunological study of fish with Clostridium botulinum toxins].
    Soma F
    Igaku Kenkyu; 1967 Dec; 37(7):892-906. PubMed ID: 4871089
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of RNA species in the RNA-toxin complex and structure of the complex in Clostridium botulinum type E.
    Kitamura M
    Biochem Biophys Res Commun; 2002 Feb; 291(1):154-7. PubMed ID: 11829476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study of botulin toxins and anatoxins by the gel filtration method. I. Studies of botulin toxins and anatoxins types A and C by filtration through Sephadex G-100].
    Freĭman VB; Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1966 May; 43(5):52-8. PubMed ID: 4975811
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clostridium botulinum type-E toxin].
    Sakaguchi G
    Nihon Saikingaku Zasshi; 1968 Mar; 23(3):155-64. PubMed ID: 4877828
    [No Abstract]   [Full Text] [Related]  

  • 31. STUDIES ON IMMUNITY TO TOXINS OF CLOSTRIDIUM BOTULINUM. IX. IMMUNOLOGIC RESPONSE OF MAN TO PURIFIED PENTAVALENT ABCDE BOTULINUM TOXIOD.
    FIOCK MA; CARDELLA MA; GEARINGER NF
    J Immunol; 1963 May; 90():697-702. PubMed ID: 14054890
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of a common cell wall antigen from the proteolytic strains of Clostridium botulinum.
    Takumi K; Kawata T
    Jpn J Microbiol; 1974 Jan; 18(1):85-90. PubMed ID: 4212113
    [No Abstract]   [Full Text] [Related]  

  • 35. Behaviour of toxin released from the cells of Clostridium botulinum type E.
    Kitamura M
    Biochem Biophys Res Commun; 1970 Aug; 40(4):925-31. PubMed ID: 4993018
    [No Abstract]   [Full Text] [Related]  

  • 36. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preparative isolation and immunochemical study of the O- and H-antigen components of Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Dec; 46(12):51-8. PubMed ID: 4986278
    [No Abstract]   [Full Text] [Related]  

  • 38. Ultracentrifugal analysis of the crystalline toxin and isolated fractions of Clostridium botulinum type A.
    Boroff DA; Townend R; Fleck U; DasGupta BR
    J Biol Chem; 1966 Nov; 241(22):5165-7. PubMed ID: 4959143
    [No Abstract]   [Full Text] [Related]  

  • 39. [An immunochemical study of serologically active substances isolated from Cl. botulinum types A and B].
    Ivanova LG; Bulatova TI; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):10-8. PubMed ID: 4969441
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alteration of the fractional composition and antigenic structure of botulin toxin E in the process of detoxication].
    Sycheva LP; Nemirovich-Danchenko MM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):117-20. PubMed ID: 4207091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.